Notas de Prensa Hereditary angioedema, a European initiative to shine a spotlight on a still under-recognized conditionH.I.G. Capital Signs Definitive Agreement to Acquire Vitaly Group through its Portfolio Company Avanta SaludNine Enterprise Security Solutions Certified in AV-Comparatives 2026 EDR Detection Validation TestIndustrial Fasteners Market: USD 113.33 Billion by 2031 with Metal Fasteners Segment Capturing 49.23% Share in 2025, Reports Mordor IntelligenceAugmentum Fintech plc - Scheme becomes EffectiveTop Racing Drivers Lead Global Challenge to Crown the World's Smartest DriverAugmentum Fintech plc - Recommended Cash Acquisition of Augmentum Fintech Plc by Frontier Bidco LimitedTeleste Launches 1.8 GHz AC Series Amplifiers to Support Today's Networks and Tomorrow's NeedsAndzonBio2, the ALBORADA Drug Discovery Institute at the University of Cambridge and Cambridge Enterprise Announce a Collaboration to Develop First-in-Class Therapeutics for NeuroinflammationAndzonBio2, el Instituto ALBORADA y Cambridge Enterprise desarrollan nuevas terapias para la neuroinflamación«2026-05-112026-05-122026-05-13«22232425262728»2026-05-142026-05-15»
Fondos de Inversion 
